Latest report
Q3 2026
filed Nov 6, 2026
Reported value
$88.3B
−$10.7B (10.8%) vs Q2 2026
Positions
29
28 in Q2 2026
Top 10 share
99.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports

Changes since Q2 2026

4 new, 1 added to, 3 trimmed, 3 exited, 21 unchanged. By estimated dollars.

New positions (4)

New positions
QCOM
QUALCOMM Incorporated
2.98MNew$547.9M
LIME
Neutron Holdings, Inc.
1.90MNew$53.5M
FRNM
Freenome, Inc.
2.02MNew$31.8M
OBX
Obsidian Therapeutics, Inc.
1.22MNew$16.8M

Added to (1)

Added to
PositionSharesChangeEst. dollars
SPCX
Space Exploration Technologies Corp.
555.04M+0.7%$581.4M

Trimmed (3)

Trimmed
LIFE
Ethos Technologies Inc.
571,907-84.2%-$102.4M
RVMD
Revolution Medicines, Inc.
2.67M-9.3%-$56.0M
FRSH
Freshworks Inc.
14.34M-11.5%-$23.9M

Exited (3)

Exited
GTLB
GitLab Inc.
2.72MExited-$83.2M
SPRO
Spero Therapeutics, Inc.
889,979Exited-$2.0M
AUTL
Autolus Therapeutics plc
698,262Exited-$1.1M

The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.

Compare two quarters

Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer